New administration technic for 7,2-hydroxy-3- (N-hydroxyethyl-N-methylamino) -propyl-1,3-dimethylxanthine, pyridine-3-carboxylate (Complamine) . Shock-dose arterioclysis
Rossano, C.; Testasecca, D.; Giugliano, F.; Memé, E.
Minerva Anestesiologica 40(3): 124-131
1974
ISSN/ISBN: 0375-9393 PMID: 4822934 Document Number: 81996
Document emailed within 1 workday
Related Documents
Balestrazzi, E.; Scorcia, G.; Ranieri, G. 1971: Clinical trial of a new corticosteroid in some aspecific inflammatory ocular diseases: dexamethasone 21-(pyridine-4-carboxylate) Annali di Ottalmologia E Clinica Oculistica 97(1): 15-22Gee, K.W.; Ehlert, F.J.; Yamamura, H.I. 1983: Differential effect of gamma-aminobutyric acid on benzodiazepine receptor subtypes labeled by [3H]propyl beta-carboline-3-carboxylate in rat brain Journal of Pharmacology and Experimental Therapeutics 225(1): 132-137
Lan, S.J.; Chando, T.J.; Cohen, A.I.; Weliky, I.; Schreiber, E.C. 1973: Metabolism of 4-(3-(dimethylamino)propyl)-3,4-dihydro-2-(1-hydroxyethyl)-3-phenyl-2H-1,4-benzothiazine (SQ 11,579) under in vitro and in vivo conditions by rats, dogs, and monkey Drug Metabolism and Disposition: the Biological Fate of Chemicals 1(4): 619-627
Mizuno, N.; Suzuki, M.; Kusuhara, H.; Suzuki, H.; Takeuchi, K.; Niwa, T.; Jonker, J.W.; Sugiyama, Y. 2004: Impaired renal excretion of 6-hydroxy-5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl) benzothiazole (E3040) sulfate in breast cancer resistance protein (BCRP1/ABCG2) knockout mice Drug Metabolism and Disposition: the Biological Fate of Chemicals 32(9): 898-901
Popendiker, K. 1970: The effect of 1-(5'-oxohexyl)-3,7-dimethylxanthine on heart rate following administration of propranolol and adenosine Arzneimittel-Forschung 20(10): 1485-1488
Gemba, T.; Ninomiya, M.; Matsunaga, K.; Ueda, M. 1993: Effects of a novel calcium antagonist, S-(+)-methyl-4,7-dihydro-3-isobutyl-6- methyl-4-(3-nitrophenyl)thieno[2,3-b]pyridine-5-carboxylate (S-312-d), on ischemic amino acid release and neuronal injury in stroke-prone spontaneously hypertensive rats Journal of Pharmacology and Experimental Therapeutics 265(1): 463-467
Ueda, M.; Masui, M.; Kawakami, M.; Matsunaga, K.; Gemba, T.; Ninomiya, M.; Nakano, A.; Torii, M.; Adachi, I.; Ito, H. 1993: Pharmacological studies on a new dihydrothienopyridine calcium antagonist. 4th communication: prophylactic and therapeutic effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4-(3-nitrophenyl)thieno[2, 3- b]pyridine-5-carboxylate in stroke-prone spontaneously hypertensive rats Arzneimittel-Forschung 43(12): 1291-1303
Nakajima, M.; Adachi, I.; Ueda, M. 1993: Pharmacological studies on a new Dihydrothienopyridine calcium antagonist. 2nd communication: effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4- (3-nitrophenyl)thieno[2,3-b]pyridine-5-carboxylate on the 1,4-dihydropyridine binding sites in the brain and on isolated arteries in the Cynomolgus monkey Arzneimittel-Forschung 43(12): 1276-1282
Yoneko, M.; Suzuki, Y.; Kojima, J. 2012: Comparative effects of low and medium molecular hydroxyethyl starch (HES) solutions on hemorrhagic shock in rats Masui. Japanese Journal of Anesthesiology 61(1): 57-63
Prostakova, T.M.; Glasko, E.N.; Khokhlova, M.P.; Polushina, T.V. 1986: Morphological characteristics of the sequelae from the parenteral administration of solutions of hydroxyethyl starch Arkhiv Patologii 48(7): 43-47
Küttel, S.; Rácz, I.; Korbonits, D. 1982: In vitro resorption study of a new anti-arrhythmia compound, N-(3,3-diphenyl-propyl)-N'-(1-phenyl-2-propyl)1,3-propylene diamine dihydrochloride Acta Pharmaceutica Hungarica 52(2): 81-90
Nakamura, A.; Hirota, T.; Sugihara, K.; Watanabe, S.; Tougou, K.; Morino, A.; Ezumi, Y.; Takaichi, M. 1997: Pharmacokinetics of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate. 2nd communication: tissue levels and enzyme activity in rats after repeated administration, and placental and milk transfer after single administration Arzneimittel-Forschung 47(2): 160-168
Agolini, G.; Cavallini, G.M. 1987: Long-term therapy of retinal vasculopathies with oral administration of high doses of O-(beta-hydroxyethyl)-rutoside La Clinica Terapeutica 120(2): 101-110
Kozlovskaia, V.E.; Grishanova, A.I.; Mishin, V.M.; Liakhovich, V.V. 1992: The effect of pyridine and pyridine-N-oxide on the monooxygenase system of rat liver microsomes Biokhimiia 57(10): 1592-1596
Nantka-Namirski, P.; Balicki, R. 1974: Dipyridyls. 3. Reactions of pyridine-3- and pyridine 4-aldehydes with malononitrile Acta Poloniae Pharmaceutica 31(3): 271-278
Jamnicki, M.; Zollinger, A.; Seifert, B.; Popovic, D.; Pasch, T.; Spahn, D.R. 1998: Compromised blood coagulation: an in vitro comparison of hydroxyethyl starch 130/0.4 and hydroxyethyl starch 200/0.5 using thrombelastography Anesthesia and Analgesia 87(5): 989-993
Dagrosa, E.E.; Hajdú, P.; Malerczyk, V.; de Looze, S.; Seeger, K.; Grötsch, H. 1987: Dose linearity and other pharmacokinetics of cefodizime after single-dose intravenous administration Clinical Therapeutics 10(1): 18-31
Czock, D.; Rasche, F.M. 2005: Dose adjustment of ciprofloxacin in renal failure: reduce the dose or prolong the administration interval? European Journal of Medical Research 10(4): 145-148
Pütter, J. 1970: Studies on absorption of salicylates. 2. Percutaneous absorption of salicylic acid 2'-hydroxyethyl ester following topic administration Arzneimittel-Forschung 20(11): 1721-1723
Lorenz, W.; Doenicke, A.; Freund, M.; Schmal, A.; Dormann, P.; Praetorius, B.; Schürk-Bulich, M. 1975: Plasma histamine levels in man following infusion of hydroxyethyl starch: a contribution to the question of allergic or anaphylactoid reactions following administration of a new plasma substitute Der Anaesthesist 24(5): 228-230